Study using RNAi reveals previously unknown mice genes linked to cancer development

January 17, 2014 by Bob Yirka report
Aggressive head and neck squamous cell carcinoma; only cells at the proliferative edges are stem cells. Credit: Daniel Schramek

(Medical Xpress)—A combined team of researchers from Howard Hughes Medical Institute and the Icahn School of Medicine has discovered a previously unknown link between absent genes and the growth of tumors. In their paper published in the journal Science, the team describes a study they conducted using RNAi and how it led to the discovery of a previously unknown genetic link to cancerous tumors.

Over the past several years, scientists have learned that genes play a far greater role in cancer development than had been previously thought. One of the things they've discovered is that in addition to genetic markers that show a predisposition to certain types of cancers, there can also be a predisposition to cancer if certain genes are absent or don't work properly, i.e. those that cause the creation of proteins or other chemicals that fight or discourage the formation of tumors. In this new study, the research team was using a relatively new technique to suppress genes—in vivo RNA interference (RNAi), a method that allows for modifying genes in an embryo that doesn't itself cause damage or changes to the embryo—to isolate genes that have been identified with tumor growth () in the head and necks of mice.

Prior to the development of in vivo RNAi, researchers would modify genetic components and then graft them onto an embryo. Though effective in some respects it also suffers from causing possible genetic changes due to immune response and also embryonic response to the wound that was created. The new method is non-invasive and allows for much more accurate placement of changed genetic material.

The researchers were using the technique to shut off different genes to learn more about what happens to mice that grow to maturity when they don't have them, i.e. which develop tumors and which don't. In so doing, the team confirmed several previously associated with development—the kind that are responsible for causing the production of proteins that fight tumors. Surprisingly, however, they also discovered seven that had never been identified before.

This discovery adds more information about cancer causing agents in mice, of course, which might be applicable to humans, but it also proves the worth of RNAi, and indicates that it might just become a major research tool in the fight against cancer in general.

Explore further: Awakening genes that suppress tumors

More information: Direct in Vivo RNAi Screen Unveils Myosin IIa as a Tumor Suppressor of Squamous Cell Carcinomas, Science 17 January 2014: Vol. 343 no. 6168 pp. 309-313 DOI: 10.1126/science.1248627

Mining modern genomics for cancer therapies is predicated on weeding out "bystander" alterations (nonconsequential mutations) and identifying "driver" mutations responsible for tumorigenesis and/or metastasis. We used a direct in vivo RNA interference (RNAi) strategy to screen for genes that upon repression predispose mice to squamous cell carcinomas (SCCs). Seven of our top hits—including Myh9, which encodes nonmuscle myosin IIa—have not been linked to tumor development, yet tissue-specific Myh9 RNAi and Myh9 knockout trigger invasive SCC formation on tumor-susceptible backgrounds. In human and mouse keratinocytes, myosin IIa's function is manifested not only in conventional actin-related processes but also in regulating posttranscriptional p53 stabilization. Myosin IIa is diminished in human SCCs with poor survival, which suggests that in vivo RNAi technology might be useful for identifying potent but low-penetrance tumor suppressors.

Related Stories

Awakening genes that suppress tumors

October 10, 2013
(Medical Xpress)—When genes that normally suppress tumor growth are themselves suppressed, cancer cells can grow and proliferate uncontrollably. A new study led by a researcher at Yale University has uncovered the pathway ...

Genetic switch shuts down lung cancer tumors in mice

October 25, 2012
Yale researchers manipulated a tiny genetic switch and halted growth of aggressive lung cancer tumors in mice and even prevented tumors from forming.

Study allows better prediction of the risk of hereditary cancer

January 15, 2014
An international study has developed a refined method to identify people at risk for certain inherited cancer as a result of Lynch syndrome.

New technique in RNA interference cuts time and cost in genetic screens

August 15, 2013
(Medical Xpress)—There is a new contender in the field of gene discovery, and it's giving knockout mice a run for their money. Researchers at The Rockefeller University have shown that a new technique using RNA interference ...

Genetic screening identifies genes driving resistance with a guide RNA library

December 23, 2013
Researchers have developed a method to create a comprehensive library of mutations across all genes in the mouse genome. This library can be used to examine the role of every gene in different cell types.

Researchers discover possible trigger for spread of head and neck cancer cells

May 8, 2013
(Medical Xpress)—Very little has been known about the epigenetic events—developmental and environmental factors affecting genes—that occur prior to the invasive growth of head and neck squamous cell carcinomas and their ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.